ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 658371 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 658371; 2) Community: the network communities that were significantly associated with the response to NSC 658371; 3) Molecule: the relationships between components within communities and NSC 658371; 4) MDR: the compounds that were significantly associated with the NSC 658371.

NSC Compound Enrichment Correlation
NSC 668300 Null 0.000864859564133839 0.29975513
NSC 670786 Null 0.000864859564133839 0.37845499
NSC 671888 Null 0.000864859564133839 0.30576923
NSC 683564 2-Butenoic acid, 4,4-dicyano-4-[[(3-thienyl)methylene]amino]-, methyl ester, (Z,E)- 0.000864859564133839 0.35469933
NSC 687011 stereoisomer of 672120 (MW=262) 0.000864859564133839 0.35512406
NSC 692587 ethyl-8-(4-chlorophenyl)-4-methyl-2-oxo-6-(thiophen-2-yl)-4a,7-dihydro-2H-chromene-3- carboxylate 0.000864859564133839 0.35633814
NSC 716679 Null 0.000864859564133839 0.43589399
NSC 718530 Null 0.000864859564133839 0.3198693
NSC 723906 1,4-di-N-oxide-6,7-difluor-2-phenylcarbonyl-3-trifluormethyl quinoxaline 0.000864859564133839 0.24304103
NSC 750970 3-[(E)-1-(3-1-[(4-fluorophenyl)sulfonyl]-4-piperidylimidazo[1,5-a]pyridin-1-yl)methylidene]-2-indolinone 0.000864859564133839 -0.3557398
Total:166  Current:14    [First] [Prev] [Next] [Last]